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Abstract 
Introduction: Wake-therapy (or "Sleep deprivation") has the potential of providing a fast 
anti-depressive response, however, the effect tends to fade after subsequent sleeping. Bright 
light therapy has the ability of maintaining the positive effect. Agitation among patients 
suffering from mood disorders has been scarcely investigated and no study has yet measured 
the possibility of increased agitation when undergoing wake-therapy. 
Objectives: To determine the effect of combined wake- and bright light therapy as an 
enhancement of existing conventional anti-depressive treatment. 
Methods: Patients suffering from a depressive episode were randomized to either wake-
therapy combined with bright light therapy in addition to treatment as usual (TAU) or to the 
control group (psycho education on sleep hygiene in addition to TAU). On day 1, before 
wake-therapy or psycho education, patients filled out Montgomery-Åsberg Depression Rating 
Scale (MADRS-S) and Insomnia Severity Index (ISI). Agitation was assessed using Positive 
And Negative Symptoms of Schizophrenia (PANSS-EC) on day 1 and 2. On day 7 all patients 
again filled out MADRS-S and ISI. 
Results: This ongoing randomized clinical trial will consist of 50 patients in total. In this 
thesis, the results from the first 8 patients is presented. Wake-therapy combined with bright 
light therapy in addition to TAU reduced the median MADRS-S score non-significantly by 6 
points,  compared to 4 points in the control group (p=0.73) ). Median ISI score was reduced 
non-significantly by 2 and 4 points, respectively (p=0.71). Agitation level among patients 
undergoing wake-therapy was not significantly raised (p=0.22). 
Conclusion: So far a non-significant reduction in MADRS-S and ISI has been observed using 
combined wake- and bright light therapy, whilst agitation levels have not been significantly 
raised. Pending the final results from this randomized controlled trial, this approach could 
become a valuable addition to conventional anti-depressive treatment, without significantly 
adding to harmful effects. 
Key words: Depressive disorders, chronobiology, sleep deprivation, phototherapy, 
psychomotor agitation (Mesh-terms). 
  
Introduction 
Depression 
During the last 50 years, the rate of diagnosed depression has become more prevalent in our 
society, at least for the mild and modest depressive states whilst prevalence of severe 
depression remains largely unchanged. Depressive disorders are among the diseases that in 
the whole world accounts for the greatest part of illness, loss of productivity and inability to 
work. In Sweden the point prevalence of depression is between 4 to 10% of the population 
and the risk of developing a depression during an individual's lifespan has been estimated to 
be approximately 27% for men and 45% for women (1). 
Sleep disturbances in depressed patients 
A symptom of depression is sleep disturbances. Sleep patterns for depressed patients vary 
widely, from clinical insomnia to hypersomnia. Sleep disturbances and insomnia in depressed 
patients has been reported to afflict as many as two out of three patients (2). The prevalence 
of suicidal tendencies for patients suffering from sleep disturbances are significantly elevated 
(3) adding to the health risks of depressed patients. Furthermore, reports indicate that inferior 
response from psychological and psychopharmacological treatment in depressed patients with 
poor sleep quality is achieved (4, 5). 
Wake-Therapy 
Wake-therapy has long been a recognized method in psychiatry, mainly used as a way of 
initiating a fast response and remission when treating patients with depressive symptoms of 
various character. More often wake-therapy is called "sleep deprivation", however this 
denomination has somewhat a negative sound and therefore the term wake-therapy will be 
used in this article concerning the therapeutic approach of keeping patients awake during the 
whole night, which often is termed total sleep deprivation (TSD) in scientific literature.  
The positive anti-depressive effect of wake-therapy usually occurs during the second half of 
the night or on the next day after wake-therapy, this happens in approximately 60 % of 
patients (6). However this effect fades after sleep on the night after wake-therapy and 
therefore duration of the positive effect is short, diminishing in a matter of days (7). Although, 
numerous clinical trials have shown considerable effect of wake-therapy on the depressive 
state of severely ill patients, both in the shorter and longer perspective (8-10). 
Bright Light Therapy 
The role of bright light therapy during treatment of depression was first established in the 
early 80’s and in 2005 APA (American Psychiatric Association) determined that it could be 
used in treating depression. Either as an alternative to or as an adjunct therapy to 
antidepressants. Later studies has shown that for non-seasonal depression the effect of light-
therapy is enhanced by as much as 30% when combined with antidepressant drugs (11, 12). 
When combining these two modalities with antidepressants the therapeutic response is fast, 
within hours and is estimated to last for weeks to months (13). 
Potential Side Effects of Wake-Therapy 
However it is also important to rule out any possible side effect that could be potentially 
harmful for patients and staff. Agitation among patients suffering from mood disorders has 
been scarcely investigated. Earlier clinical trials using wake-therapy has sporadically reported 
on side effects such as hypomania and irritability which relates to agitation (9). To our 
knowledge no study has yet measured the possibility of increased agitation when undergoing 
wake-therapy. Recent research on the Swedish population found that patients suffering from 
depression has a significantly increased risk of performing violent crimes (14), indicating that 
a depressed patient may have a higher risk of becoming agitated or aggressive. Agitation can 
be considered as a potential security risk not only for the patient undergoing treatment but 
also for other admitted patients and for the staff. Furthermore, agitation increases the length of 
stay, leads to more frequent re-admission to psychiatric wards and moreover, agitated patients 
have a tendency to require a larger amount of medication while admitted (15). In turn this 
causes higher health costs overall when treating agitated patients.  
 
Necessity of additional interventional strategies in the treatment of depression 
Antidepressant drugs generate an antidepressant effect after 4 to 6 weeks (16), which might 
seem like a short duration from initiation of therapy and onset of effect when comparing many 
other pharmaceuticals. Considering the severe risks that a depressed patient faces in terms of 
suicide and suffering, this delay of effect could mean the difference between life and death for 
some patients. A more rapid, and at the same time safe, therapy should be available for 
inpatients suffering from severe depressive disorders in order to ensure their wellbeing. Wake 
therapy has yet not become general practice in psychiatric wards but has the potential of 
providing superior response of conventional anti-depressive treatment without adding to 
harmful effects. Prior to this randomized clinical trial, a pilot study comprising 10 patients 
was executed in 2014 that indicated positive effects from wake- and bright light therapy with 
remission from depression in 30 % of subjects whilst reported side effects were insignificant 
(17). The need for further studies on chronotherapeutic approaches when treating patients 
suffering from depressive episodes is still great and in order to be able to use wake-therapy 
and light therapy as a routine in psychiatric wards the need for more conclusive evidence is 
still sought for. 
  
Aim 
This randomized clinical trial is aimed at determining the effect of combined wake- and bright 
light therapy as an enhancement of existing conventional anti-depressive treatment of various 
categories. Primary effect outcome is self-assessed alteration in depression after one week of 
treatment, reflecting a patient oriented view concerning improvement of remission during a 
depressive episode.  
Furthermore, level of agitation was recorded among patients included in the clinical trial. We 
hypothesize that agitation may be a potential side effect to wake-therapy and therefore 
agitation was assessed and measured.  
  
Material and Methods 
Inclusion and Exclusion 
Patients admitted to a closed psychiatric ward at Östra/Sahlgrenska University Hospital due to 
a depressive episode were screened for eligibility. The primary inclusion criteria were 
depressive episode, whether it may be of the unipolar, bipolar or chronic type. Multiple 
psychiatric diagnoses were included, however, a list of exclusion criteria was applied for 
ethical and safety reasons: 
 Pregnant women 
 Manic/hypomanic state or a diagnosis of bipolar disorder without mood-stabilizing treatment 
 Epilepsy 
 Age <18 or >65 years 
 Ongoing psychosis 
 Ongoing alcohol- or drug use disorder 
 Ongoing compulsory psychiatric care 
 Retinal dystrophies or age-related macular degeneration 
 Porphyria, systemic/discoid lupus, chronic actinic dermatitis or solar urticaria  
Reasons for exclusion are directly related to potentially harmful effects of either wake-therapy 
or bright light therapy (6). Pregnant women were mainly excluded due to ethical 
considerations. Alcohol or drug misuse would be a profoundly confounding factor when 
interpreting our results and therefore these patients were excluded. An anonymous list of all 
patients excluded after screening was archived including diagnosis, gender and age. 
  
Screening 
Screening included several questionnaires and diagnostic tools in order to determine if 
patients were eligible.  
Mini International Neuropsychiatric Interview (MINI) was used to establish the diagnosis of a 
depressive episode, a widely used standardized interviewing method with good diagnostic 
properties (18) aimed at examining and detecting certain symptoms indicating specific 
psychopathological conditions. For this study parts A, B and C of the MINI were used as 
these are aimed at Major Depressive episode (A), Suicidality (B) and Bipolar Syndrome (C) 
in order to strengthen clinical diagnosis of a depressive episode which is the main inclusion 
criteria.  
Alcohol Use Disorders Identification Test (AUDIT) and Drug Use Disorders Identification 
Test (DUDIT) are both self-assessed questionnaires quantifying the amount of alcohol and 
drugs (non-prescribed) used by the patient, this aids in detecting any possible misuse or 
addiction that could lead to exclusion. 
Morning-Eveningness Questionnaire (MEQ) assesses the circadian rhythm through 19 
specific self-assessment questions. MEQ is a validated (6, 19) questionnaire determining a 
person’s chronotype, pinpointing the appropriate sleeping-time, and also can give a valid 
indication as to what the optimal time would be for a patient to receive bright light therapy. A 
translated version was used which has shown high internal reliability among a Swedish cohort 
(20). 
To follow anti-depressive response, the self-assessed version of Montgomery-Åsberg 
Depression Rating Scale (MADRS-S) which consists of 9 items with a scale of 7 on each item 
(0-6) rating severity of depressive symptoms. Self-rating on MADRS-S has shown good 
correlation with expert assessment of depressive symptoms (21, 22) and is superior in 
measuring response to anti-depressive treatment compared with other rating scales (23).  
To measure the severity of sleep disturbance experienced by the patients before entering the 
study we used the self-assessed Insomnia Severity Index (ISI) that is made up of 7 items with 
a scale of 5 (0-4) on each item. The ISI is a valid questionnaire that can detect clinical 
insomnia and give a relevant depiction of sleep disturbances (24, 25). 
Clinical Global Impression of Severity (CGI-S) was used to take into consideration the 
physicians assessment in addition to the patients self-assessed MADRS-S. The estimation in 
the CGI-S is highly influenced by the amount of clinical experience and varies between 
physicians.  
Positive And Negative Symptoms of Schizophrenia (PANSS) is a medical scale used on 
patients suffering from schizophrenia and contains several questions assessing agitation-level. 
The Positive And Negative Symptoms of Schizophrenia - Excited component (PANSS-EC) is 
a validated (26) modified version of the PANSS consisting of five items (Excitement, 
Hostility, Tension, Uncooperativeness and Poor impulse control) aimed at measuring the 
agitation level only in patients.  
Study protocol 
Patients included in the trial were block randomized using a randomization programme online 
to either wake-therapy combined with light therapy in addition to conventional anti-
depressive treatment or to psycho education on sleep hygiene in addition to conventional anti-
depressive therapy. After randomization patients were informed on the protocol for the 
forthcoming week and the latter follow-up as depicted in figure 1.  
 Patients in the wake- and bright light therapy were encouraged to stay awake for the whole 
night (day 1) and to go to sleep on the following night (day 2) on the appropriate sleep onset 
time as concluded in the MEQ. In the morning after wake-therapy (day 2) patients received 30 
min of bright light therapy on the appropriate start time as concluded in the MEQ, bright light 
was thereafter administered on this time on the forthcoming days and in total, each patient 
received 6 sessions of bright light therapy during 6 days (day 2-7). Each session of bright light 
Figure 1. Flow chart describing study protocol. 
 
therapy has a duration of 30 min, there is no need for longer sessions as the aim is merely to 
mimic a springtime sunrise (6). 
The patients randomized to psycho education received a short psycho educative session in 
sleep hygiene, that was constructed by the author, based upon current cognitive behavioural 
therapy models concerning sleep disturbances (27), and carried out by a specialist nurse in 
psychiatry. The psycho educative template can be found in "Appendices". Considerations 
were made concerning the option not to offer anything to this group since it is the control 
group, however, such an approach could come across as a negative factor for patients in this 
group and could bias end results by introducing a potential nocebo effect. 
Both groups received psychopharmacologic treatment as usual and physicians was blinded to 
which group a patient would be randomized to after screening and inclusion to the trial. 
On day 1, before wake-therapy or psycho education, patients in both groups filled out the self-
assessed MADRS-S and ISI. In addition, all patients were rated by the treating physician 
using CGI-S on day 1 (results not presented in this thesis). On day 7, after one night of wake-
therapy and 6 times of bright light therapy or alternatively only psycho education on sleep 
hygiene, patients again filled out the MADRS-S, ISI and were assessed using CGI-S. Other 
randomized trials has used this time interval and it has been sufficient to establish significant 
differences between groups exposed to wake- and/or bright light therapy compared to control 
groups (16, 28, 29). Approximately three months after discharge, patients will meet a 
psychiatrist that has no knowledge of what treatment the patient was randomized to and again 
fill out the MADRS-S and ISI. Comparison can thereafter be made between the two groups 
concerning changes in the MADRS-S, ISI and CGI score.  
All patients were also requested to fill out a customized feedback questionnaire concerning 
the wake- and bright light therapy alternatively the psycho educative session at day 1,7 and 
after 3 months. The questionnaire can be found in "Appendices". 
On day 1 all patients in both groups was assessed by a doctor or nurse using the PANSS-EC. 
On day 2 all patients in both groups was subjected to a second assessment to evaluate any 
changes in agitation after initiation of either wake-therapy in addition to conventional anti-
depressive treatment or conventional anti-depressive therapy only. The psycho educative 
group will be considered as a control group due to the fact that there is no expected significant 
change in agitation from one day to the other when unexposed to additional stressing factors. 
Before patient enrolment the study protocol was registered at Clinical Trials (NCT02503124), 
which facilitates full disclosure of our findings regardless of the outcome and in turn helps 
other clinicians in customizing studies and avoid publication bias. The primary outcome 
registered in that protocol is the number of patients with a reduction >50% on MADRS-S. 
  
Ethics 
The ongoing clinical trial at Östra/Sahlgrenska University Hospital involving admitted 
patients suffering from depressive symptoms is performed to evaluate the effect of wake-and-
light therapy and potentially include this treatment as a possible standard treatment available 
for this patient group. In general, negative effects of conducting the study are few if any. 
Ethical aspects were taken into consideration when constructing the study design. The 
PANSS-EC interview is a non-invasive assessment and does not violate patient integrity. The 
assessment forms does not contain patient sensitive information and can’t be connected to a 
specific patient by staff or any other person outside of the project. Ethical approval for the 
clinical trial has been granted by the regional ethics committee in Gothenburg, dnr Ö 11-2014, 
and the Helsinki Declaration provided the ethical guidelines for this master thesis. No 
individual is identifiable in the written document. 
 
  
Data analysis and Statistical methods 
In order to guarantee anonymity all data has been depersonalized and collected into an excel 
sheet only accessible by the author. All statistical analyses were made using IBM SPSS 
statistics 21.0.0. (SPSS Inc, Chicago, IL, USA). To determine if the different sets of data from 
the two groups are significantly different from each other, a t-test has been used on the mean 
differences for each analysis. Based on power calculations a total of 50 patients will be 
included and at the writing of the thesis 8 patients have been randomized. 
  
Results 
Demographics 
At present, a total of 8 patients have been randomized (mean age 34, 75 % women). The 
psycho educative group consists of five patients (mean age 29, 80 % women) and the wake- 
and bright light therapy group comprises three patients (mean age 42, 67 % women). All 
patients fulfilled the criteria for a depressive episode according to MINI and one had bipolar 
disorder. 
Differences in treatment was considerable and there was no intention of influencing the 
decision on which anti-depressant the patients should be treated with. Anti-depressants on day 
7 is described for each patient as well as any mood stabilizing treatment, displayed in the 
demographic overview below (Table 1). Patient no. 2, in the psycho educative group, had a 
mood stabilizer for bipolar disorder. The same patient was re-admitted to a closed psychiatric 
ward shortly after discharge. None of the other patients had been re-admitted to a psychiatric 
ward when last checked on 24th of November 2015. 
Table 1. Overview of the first 8 patients randomized to Wake- and Bright Light 
Therapy or Psycho education 
Pat. Treatment arm Age/Sex Antidepressant/Mood stabilizer Re-admission 
1 Psycho education 23/W Sertralin / None No 
2 Psycho education 39/W Venlafaxin + Mirtazapin / Valproate Yes 
3 Wake + bright light therapy 46/W Escitalopram / None No 
4 Wake + bright light therapy 27/W Escitalopram / None No 
5 Psycho education 38/M Venlafaxin / None No 
6 Wake + bright light therapy 52/M Anafranil / None No 
7 Psycho education 27/W Citalopram / None No 
8 Psycho education 20/W Sertralin / None No 
    
 
  
Depression 
The mean reduction of MADRS-S score was 7.0 (Std.dev 12.4) in the whole group. This was 
non-significant (p=0.71) between the groups. In the wake- and bright light therapy group the 
mean reduction was 4.7 (Std.dev 7.1) compared to the psycho educative group where the 
mean reduction was 8.4 (Std.dev 15.3). Analyzing the median for the groups there was a 
reduction of 5 points in the whole group. In the wake- and bright light therapy group the 
median reduction was 6 compared to the psycho educative group where the median reduction 
was 4 (Figure 2). 
 
 
Figure 2. Median reduction in MADRS-S score on day 7 among randomized patients (n= 8) 
to Psycho education (n= 5) and wake-therapy combined with bright light (n= 3) respectively. 
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Insomnia 
Concerning severity of insomnia, measured as reduction in ISI score, a mean reduction of 4.3 
(Std.dev 5.3) was found in the whole group. This was non-significant (p=0.73) between the 
groups. In the wake- and bright light therapy group the mean reduction was 3.3 (Std.dev 2.3) 
compared to the psycho educative group where the mean reduction was 4.8 (Std.dev 6.7). 
Analyzing the median for the groups there was a reduction of 3 in the whole group. In the 
wake- and bright light therapy group the median reduction was 2 compared to the psycho 
educative group where the median reduction was 4 (Figure 3). 
  
 
Figure 3. Median reduction in ISI score on day 7 among randomized patients (n= 8) to 
Psycho education (n= 5) and wake-therapy combined with bright light (n= 3) respectively. 
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Agitation 
No increased agitation measured with PANSS-EC was present for 7/8 patients on day 1 or day 
2 respectively. Only one patient was scored 3 (mild) concerning excitement on the day after 
wake therapy. A mean increase of 0.3 (Std.dev 0.7) was found in the whole group. There was 
no significant difference in agitation level on day 2 between the groups (p=0.22). In the wake- 
and bright light therapy group the mean increase was 0.7 (Std.dev 1.2) compared to the 
psycho educative group where there was no increase in agitation. The median alteration in 
both groups were 0.  
Patient questionnaire  
Feedback from patients concerning how they perceived the chronotherapeutic intervention 
given revealed that overall experiences from participation was positive and generally all 
patients reported that they had somewhat been helped by the intervention, regardless of group.  
Patients in the wake- and bright light group overall thought that the intervention was a modern 
treatment, would have participated if they were asked again, would recommend it to a friend 
suffering from similar symptoms and that the intervention should be available for all patients 
that would like it. None thought that there were any side effects, however one patient 
complained that the brightness of the light source made it hard to constantly look at it for 30 
minutes. When asked about if they had any difficulties with their chronobiologic treatment, 
two patients reported they had some difficulties which mainly concerned trying to keep awake 
during the first night.  
All patients in the psycho educative group but one (no.8, see table 1) thought that the 
intervention was somewhat modern, would have participated if they were asked again, would 
recommend it to a friend suffering from similar symptoms and that the intervention should be 
available for all patients that would like it. Several thought that there were side effects, 
however they did not specify any side effect that logically could be related to the psycho 
educative measures, but rather side effects overall during the week. When asked about if they 
had any difficulties with their chronobiologic treatment, four patients reported they had 
difficulties, whilst one patient (no.5, see Table 1) had none. One of the patients (no.2, see 
table 1) was very positive towards psycho education, was very satisfied with it in all aspects , 
reported no side effects and commented that she would continue to work on sleep hygienic 
measures after discharge.  
Discussion 
This randomized clinical trial has so far included 8 patients and the results presented are 
preliminary since a total of 50 patients will be included. So far the reduction in MADRS-S 
and ISI is not statistically significantly different. Due to the fact that the study sample is still 
small, with five patients in the control group and three patients in the wake- and bright light 
therapy group, statistic tests cannot yet be performed with certainty to reveal if there are 
significant positive anti-depressive effects to be drawn from the chronotherapeutic approach 
used in this study. Reported in this study are the mean and median reduction in MADRS-S 
and ISI score. We have emphasized the difference in median reduction rather than the mean, 
since the study population is small and at present consists of values with a large variability. A 
large proportion of the variance in the psycho educative group stems from one patient (no.2), 
the only bipolar patient so far, which reported 54 points (highest score) on MADRS-S upon 
inclusion and 19 points after one week. After discharge this patient was soon re-admitted and 
did then report the occurrance of a hypomanic/manic state shortly after being discharged. 
Hence, there are some concerns that this episode could have contributed to the sudden effect 
seen in MADRS-S for this patient.  
When the study population reaches a larger size, it is more motivated to use a students t-test, 
comparing mean reduction in the groups, as well as Fishers exact test (e.g. how many patients 
obtains a 50% reduction in MADRS-S score after 7 days?) to more accurately describe the 
effects of chronotherapeutic treatment. Continuation of the study is still highly motivated as 
several earlier studies have proven to provide good effect on depressive episodes using 
chronotherapeutic treatment (8, 10-13). 
Martiny et al (16) used a similar approach in a 9 week RCT which showed rapid and 
significant antidepressant response compared to placebo (exercise) after wake-therapy and 
bright light therapy in over 40 % of patients and total remission in almost 24 % after 1 week 
of intervention. However, sleep time stabilization was also included in this study and could 
account for a part of the effect shown in that study. They also generalized the choice of 
antidepressant for patients, giving them duloxetine, which differs from the approach used in 
our protocol. As our study population so far indicates that a great variety of antidepressants 
are used, this in effect becomes a confounding factor for our results. Different 
psychopharmacologic treatment could account for the differences seen in anti-depressive 
response. But, on the other hand, as our patients are not subjected to generalized treatment 
they benefit from individualized treatment and instead, if differences ultimately can be seen in 
this trial, that are not directly related to a significant difference in antidepressants, then this 
chronotherapeutic approach could be used by a wider category of patients. 
In this trial the patients randomized to psycho education are considered as controls. As in the 
study mentioned above, this group was not completely without intervention. One might argue 
that patients receiving a psycho educative session on sleep hygiene logically might experience 
a positive effect on both sleep disturbances and ultimately also on malaise. However, the 
session was short and given only once by a nurse without professional education on cognitive 
behavioral therapy. It was based on a short template (see Appendices) summarized by the 
author, whom likewise has restricted knowledge and experience on cognitive behavioral 
therapy. That said, patients experiencing effect, if any, from this intervention is likely to be 
positive which would tend to reduce the discrepancy in positive effect between the two 
groups. Therefore any significant difference between the two groups rather strengthens than 
weakens the thesis that wake-therapy combined with bright light quickens remission in 
depressed patients. 
On the contrary, by actively informing about the study and potential effects during screening 
in order to include a patient it might affect the patient negatively if they were to be offered 
nothing and simply be told that they are "controls". By formally informing about two different 
intervention protocols and that randomization will choose which kind, the patient still feels 
like something has been gained by accepting participation and the confounding factor of 
attention and extra care is somewhat reduced. 
Although the Swedish population is generally well-educated in the English language, efforts 
were made to present all questionnaires and information in Swedish. This should have a 
tendency to minimize possible misunderstandings during self-assessment and increase 
compliance overall in the trial concerning instructions on wake- and bright light therapy as 
well as psycho educative measures. 
MADRS-S is routinely used by the psychiatric care in Gothenburg and patients in this study 
had all been presented to this type of self-assessment prior to admission. Not all patients were 
familiar with the ISI, but instructions are clear and easy to understand, no patients reported 
any problems whilst filling out this questionnaire. As this type of self-assessment correlates 
well with objective expert opinion concerning depressive symptoms (21, 22) and insomnia 
(24, 25) we consider that changes in total score is a good reflection of improvement and 
practically without any rater bias. 
Assessing agitation in this trial showed that there was little to nothing to measure as patients 
overall did not present with any symptoms of an agitated value. Only one patient presented 
with heightened excitation one the day after wake-therapy, excitation level was rated as mild. 
Due to logistic reasons, it was not possible at all times that patients could be rated according 
to PANSS-EC by the same rater. Therefore, on some patients, different raters have assessed 
agitation on day 1 and 2. However, clear and simple instructions were attached with the rating 
form on how to assess agitation. Although this approach entails that inter rating reliability has 
to be considered and could bias the result. One must also remember the fact that PANSS-EC 
is primarily aimed at measuring agitation or aggressiveness in psychotic patients and therefore 
the threshold for rating increased level of agitation is somewhat higher than one might have 
wished. But the lack of tools in assessing agitation on depressed patients leaves no other 
choice but to use scales of this sort. A need for more thorough investigation concerning 
prevalence of agitation in depressed patients and how to best assess it seems to be still needed.  
Feedback from the patients that have underwent the study protocol so far revealed that overall 
patients are positive about participating and has not experienced any severe side effects, even 
if some side effects were reported on the sheet in the psycho educative group. Those 
described are more likely related to medications, however if there is a predominant 
occurrence of side effects in either group one must consider that they could relate to that 
specific intervention. Regardless of this, the feedback in general does support that the trial 
should proceed. 
In the study mentioned earlier, performed by Martiny et al, they added  a later follow-up of 
the same study population, where they noticed that response and remission rates continued to 
improve and was significantly higher for the wake- and bright light therapy group after 20 
weeks (8), indicating that the effect of wake and bright light therapy may not only be 
considered as a procedure with merely short term effects. Potentially, our results from the 
three month follow-up in this study will contribute with more knowledge concerning the anti-
depressive effect in terms of response, remission and prevalence of relapse in the somewhat 
longer perspective. 
 
  
Conclusion and Implications 
In this randomized controlled trial involving the first 8 patients out of a total of 50 patients , a 
non-significant anti-depressive effect, measured as reduction in self-assessed MADRS-S 
score, from wake-therapy combined with bright light therapy in the morning for one 
consecutive week was found. A non-significant correlation concerning improved sleeping 
patterns, measured as reduction in self-assessed ISI score, was also established. Although 
non-significant, reduction in ISI score was greater in the control group. Concerns about 
possible increase of agitation when undergoing wake-therapy were appeasing as only one out 
of three patients were assessed with elevated excitation (one out of five items in the PANSS-
EC) to a mild degree. Comparison between the groups revealed that agitation level was not 
significantly raised after wake therapy.  
A need for further studies investigating the probable positive effects, and possible side effects, 
from chronotherapeutics is still much needed. The continuation of this randomized controlled 
trial will hopefully strengthen the scientific evidence of this interventional approach when 
treating patients suffering from depression so that remission may be greater and quicker.  
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Populärvetenskaplig sammanfattning 
Randomiserad Klinisk Studie Gällande Effekten av En Hel Natts Vakenhet Efterföljt av 
Ljusterapi vid Depression 
Depression är en vanligt förekommande sjukdom i den svenska befolkningen. Den behandling 
som i dagsläget är tillgänglig för personer som lider av depression består av i första hand 
kognitiv beteendeterapi och antidepressiva läkemedel, samt i svåra fall elektrokonvulsiv 
behandling. De flesta patienter som läggs in för psykiatrisk vård blir insatta på antidepressiva 
läkemedel, men den antidepressiva effekten av dessa dröjer normalt 4-6 veckor. Belastningen 
på den psykiatriska vården i Sverige är idag hög och oftast kan inte patienterna kvarstanna 
ända tills man sett den positiva effekten av antidepressiva. Ett behov av snabbare effekt och 
därmed kortare tid till återhämtning tycks finnas. Därför har en klinisk studie initierats för att 
undersöka om en hel natts vakenhet i kombination med en veckas ljusterapi varje morgon kan 
påskynda den antidepressiva effekten av läkemedel.  
Det är sedan länge känt att vakenhet har en snabbt insättande antidepressiv effekt, problemet 
är att denna effekt ofta avtar efter det att patienten går och lägger sig på efterföljande natt. Vår 
teori var att man skulle kunna upprätthålla effekten genom att behandla patienterna med 
ljusterapi varje morgon i en vecka efter att man varit vaken en hel natt. Liknande studier som 
gjorts med denna kombination har noterat att detta verkar fungera. En del studier med 
vakenhetsterapi har sporadiskt rapporterat kring biverkningar av vakenhet såsom 
uppvarvning, irritation och orolighet. Vi ville därför också noggrannare undersöka om 
patienterna uppvisade dessa symptom efter att ha varit vakna en hel natt. 
För att mäta om denna metod verkligen är effektiv så skedde ett slumpmässigt urval där 
patienterna antingen mottog vakenhetsterapi i kombination med ljusterapi eller istället fick en 
kort utbildning i sömnvanor och sömnbeteende. Varken patienter eller läkare visste vilken 
grupp som varje patient skulle väljas ut till. För att kunna mäta skillnaden mellan grupperna 
fick patienterna fylla i skattningsformulär gällande både depressiva symptom och sömnbesvär 
innan de gick med i studien. Sedan fyllde de i samma formulär när en vecka passerat. 
Skillnaden i minskning av depressiva symptom och sömnbesvär kunde sedan jämföras. 
Då det är en pågående studie som hittills består av 8 patienter så är nuvarande underlag för 
litet för att man ska kunna dra några slutsatser. Målet är att 50 patienter ska ha genomgått 
behandlingen och sedan kan noggrannare analys utföras. De preliminära resultaten visar på en 
median reduktion av antidepressiva symptom som är 50 % större i gruppen som genomgått 
vakenhets- och ljusterapi jämfört med gruppen som fick utbildning gällande sömnen. Den 
mediana minskningen av sömnbesvär var endast hälften så stor efter vakenhets- och ljusterapi 
jämfört med utbildning gällande sömn. Gällande ökad oro, irritabilitet och uppvarvning så 
kunde man inte se någon tydlig ökning av dessa symptom bland patienter som varit vakna en 
hel natt. 
Sammantaget tycks vakenhets- och ljusterapi vid depression kunna ge en viss antidepressiv 
effekt, hur stor denna är kommer att visa sig när alla 50 patienter genomgått studien. Vår 
förhoppning är att denna behandlingsmetod kan bli en del av behandlingsarsenalen vid 
depression om den visar sig effektiv. 
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Psykoedukation i sömn 
Introduktion 
Patienter inkluderade i det pågående forskningsprojektet kring Kronobiologiska metoder som after 
randomisering ingår i gruppen ”Psykoedukation i sömn” ska erhålla ett samtal à ca 20 min med 
läkare eller sjuksköterska kring sömnhygien. Mallen nedan är tänkt som ett stöd i detta samtal och 
baserar sig på rådande kognitiv beteendeterapi kring sömnstörningar (KBT inom psykiatrin, Natur & 
Kultur 2013). 
Beteendeanalys 
Beteende rörande sömn är viktigt att kartlägga för att kunna ge patienten möjlighet till lämplig 
reflektion och insikt. Fråga in till: 
 Typiskt sömnmönster, tag även hjälp av ISI-skattningsskalan 
 Aktiviteter i förbindelse med sömn (fysisk träning, spännande bok/film,  
 Intag av centralstimulerande medel (nikotin, koffein). När och hur mycket? 
 Hur lång tid tar det från det att man lägger sig i sängen till insomning? 
 Aktivitetsnivå under dagen 
Målet med KBT  gällande sömn är att patienten själv ska beskriva vad som är problematiskt med sin 
sömn och vad den tror är möjligt/lämpligt att förändra för att sömnen ska bli bättre. Målsättningen är 
alltså snarare självinsikt än ”goda råd”. 
Skillnaden mellan Trötthet och sömnighet 
En vanlig missuppfattning hos patienter med sömnbesvär är att de upplever ett behov av att sova när 
de känner sig ”trötta”. Trötthet kan betraktas som en känsla förknippad till hög grad av mental 
och/eller fysisk spänning/aktivering och kan inte förväntas avhjälpas av sömn enbart. Trötthet kan 
också ha sin grund i många kroppsliga sjukdomar och kan inte enbart skyllas på sömnen.  
Sömnighet är relaterat till vissa kroppsliga upplevelser så som gäspningar, ”grus i ögonen”, svårighet 
att hålla ögonen öppna och muskulär avslappning. Dessa signaler ska av patienten tolkas som ett 
behov av att sova och det är då lämpligt att gå och lägga sig för att invänta den ofrivilliga 
insomningen. 
Fem förtydliganden om sömn 
Patientens inre och yttre händelser (stress, sociala konflikter etc) bidrar till en variation i 
sömnkvalitén. 
Det finns inga tekniker som kan användas för att somna. Variation till en viss grad måste tillåtas 
eftersom sömnen inte står under viljemässig kontroll 
En sömnlös natt är ingen katastrof. Även om man sovit dåligt klarar man av morgondagen. 
En natt av dålig sömn kompenseras automatiskt nästkommande nätter och resulterar i en djupare, mer 
utvilande sömn ( ökad deltasömn). 
Genom nya kunskaper och vanor gällande sömn kan sömnen förbättras på sikt. Det är en process som 
tar tid. 
   
Stimuluskontroll 
Det finns ett antal förhållningssätt och regler kring sömn som patienten behöver ha kännedom och 
insikt i för att på sikt uppnå och bibehålla en regelbunden dygnsrytm med god sömnkvalitet.  
Lägg dig att sova enbart när du känner dig sömnig 
Bestäm inte en regelbunden läggningstid på förhand 
Lyssna till din inre sömnighet. Trötthet och sömnighet är olika upplevelser. 
Vid tecken till sömnighet -> gå och lägg dig (ej dagtid) 
Använd sängen enbart till att sova i 
Sängen ska förknippas med sömn  
Undvik aktiverande sysselsättningar (Ex. tv-tittande, läsning, problemlösning etc.) i sängen 
Sexuell aktivitet är tillåten 
Viktigt att knyta tillbaka till beteendeanalysen här. Om patienten exempelvis läser och faller i sömn 
av detta är det fortsatt lämpligt beteende. Men om patienten utför aktiverande sysselsättningar som 
försvårar insomnandet så är det olämpligt beteende 
Om du inte kan somna -> Stig upp och gör något annat 
För lång tid i vaket tillstånd i sängen medför negativ betingning mellan sömn och säng.  
Ligg ej vaken längre än 20 min. 
Stig istället upp och förflytta dig till annat rum 
Ägna dig åt något som ej är krävande. Exempelvis läs något lättläst i en lugn och tyst miljö. Relatera 
tillbaka till beteendeanalys kring aktiviteter som patienten upplever som avslappnande och som 
bidrar till sömnighet. 
När du märker tecken till sömnighet -> återvänd till sängen och invänta den ofrivilliga insomningen. 
Om du fortfarande inte kan somna -> Stig upp på nytt 
En av de svårare reglerna att förhålla sig till. 
Viktigt för att säkerställa en positiv betingning mellan sömn och säng.  
Detta moment kan behöva genomföras flera gånger per natt i början. 
Stig upp samma tid varje morgon 
Väckarklocka/alarm ska vara ställd på samma tid varje morgon. Alla dagar, även helg. 
Stig upp när klockan/alarmet ringer varje morgon oavsett hur mycket du sovit eller hur trött du är. 
Ligg inte kvar vaken i sängen efter väckningstiden. 
Sov inte på dagtid 
För att förankra en hälsosam dygnsrytm. 
För att tydligt koppla sömn till nattetid och sängen. 
Psykoedukativ mall utformad av Mats Widmark-Jensen 
för användning i Kronobiologisk studie vid Östra Sjukhuset 
 
 
 
 Utvärdering av kronobiologiska behandlingsmetoder på avdelning 363 
Frågorna nedan skattas från 1 = instämmer inte alls till 5 = instämmer helt och gäller endast 
given kombinerad ljusterapi och vakenhetsterapi alternativt psykoedukation i sömnhygien 
under vårdtillfället. 
1. Jag blev hjälpt av kronobiologisk behandling 
1 2 3 4 5 
2. Jag upplevde svårigheter med min kronobiologiska behandling 
1 2 3 4 5 
3. Detta känns som ett modernt sätt att behandla psykiska störningar 
1 2 3 4 5 
4. Jag upplevde detta som tvångsbehandling/tortyr 
1 2 3 4 5 
5. Om jag kunde välja igen skulle jag ha samtyckt till behandlingen 
1 2 3 4 5 
6. Jag skulle rekommendera behandlingen till en närstående med liknande besvär 
1 2 3 4 5 
7. Denna behandling borde vara tillgänglig för patienter som önskar denna 
1 2 3 4 5 
8. Jag upplevde inga biverkningar 
1 2 3 4 5 
I fall du upplevde biverkningar kan du vänligen beskriva dessa: 
_________________________________________________________________________________
_____________________________________________________________________ 
Övriga kommentarer: 
_________________________________________________________________________________ 
Tack för din hjälp till att förbättra kronobiologisk behandlingsmetod! 
 
 Patientenkät för användning i Kronobiologisk studie vid Östra Sjukhuset 
 
 
 
